Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 9 Similar Profiles
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Hormones Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1998 2023

Research Output 1986 2017

Dorsal Muscle Attenuation May Predict Failure to Respond to Interleukin-2 Therapy in Metastatic Renal Cell Carcinoma

Otemuyiwa, B., Derstine, B. A., Zhang, P., Wong, S. L., Sabel, M. S., Redman, B. G., Wang, S. C., Alva, A. S. & Davenport, M. S. Sep 1 2017 In : Academic Radiology. 24, 9, p. 1094-1100 7 p.

Research output: Research - peer-reviewArticle

Renal Cell Carcinoma
Interleukin-2
Muscles
Therapeutics
Neoplasms
4 Citations

Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2

Stenehjem, D. D., Toole, M., Merriman, J., Parikh, K., Daignault, S., Scarlett, S., Esper, P., Skinner, K., Udager, A., Tantravahi, S. K., Gill, D., Straubhar, A. M., Agarwal, A. M., Grossmann, K. F., Samlowski, W. E., Redman, B., Agarwal, N. & Alva, A. Aug 1 2016 In : Cancer Immunology, Immunotherapy. 65, 8, p. 941-949 9 p.

Research output: Research - peer-reviewArticle

Renal Cell Carcinoma
Interleukin-2
Survival
Therapeutics
Disease-Free Survival
31 Citations

Safety and efficacy of nivolumab in patients with metastatic renal cell carcinoma treated beyond progression

George, S., Motzer, R. J., Hammers, H. J., Redman, B. G., Kuzel, T. M., Tykodi, S. S., Plimack, E. R., Jiang, J., Waxman, I. M. & Rini, B. I. Sep 1 2016 In : JAMA Oncology. 2, 9, p. 1179-1186 8 p.

Research output: Research - peer-reviewArticle

Renal Cell Carcinoma
Safety
nivolumab
Therapeutics
Response Evaluation Criteria in Solid Tumors
2 Citations

Use of preoperative PET/CT staging in sentinel lymph node-positive melanoma

Scheier, B. Y., Lao, C. D., Kidwell, K. M. & Redman, B. G. Jan 1 2016 In : JAMA Oncology. 2, 1, p. 136-137 2 p.

Research output: Research - peer-reviewLetter

9 Citations

A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma

Kudchadkar, R., Ernst, S., Chmielowski, B., Redman, B. G., Steinberg, J., Keating, A., Jie, F., Chen, C., Gonzalez, R. & Weber, J. May 1 2015 In : Cancer Medicine. 4, 5, p. 643-650 8 p.

Research output: Research - peer-reviewArticle

docetaxel
Melanoma
YM 155
Survival Rate
Disease-Free Survival